Cytomegalovirus (CMV) Infection - Epidemiology
Insights-2023- United States” Reports provides an overview of the disease and
the historical and forecasted epidemiological data of the Cytomegalovirus (CMV)
Infection for the United States for 2013-2023.
The report considers the transplant patients, HIV patients
and Infants under high risk for CMV infections and epidemiology forecast for
these high risk categories have also been taken into consideration. Out of all
these high risk categories, CMV is more prevalent among the Transplant patients
than HIV patients and Infants. As per Publisher’s estimation, the total number
of Diagnosed CMV Infection cases in United States is expected to increase at a
CAGR of 0.041% to 77,726 cases in 2023.
The report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house Forecast
model analysis by Publisher team of industry experts.
Scope
- Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
- Identifying patient populations in the United States Cytomegalovirus (CMV) Infection market
- The Report covers the detailed historical and forecasted epidemiological data covering United States from 2013-2023.
Spanning over 60 pages, 8 Tables and 8
Figures “Cytomegalovirus
(CMV) Infection - Epidemiology Insights - 2023 - United States” report covers Cytomegalovirus
Infections, Disease Overview, Symptoms of cytomegalovirus (CMV) Infection,
Epidemiology and Patient Population, Report Methodology, Appendix.
For
more information Visit at: http://mrr.cm/3ms
Related Reports;
Cytomegalovirus
(CMV) Infection- Epidemiology Insights-2023- EU5 - Visit at - http://mrr.cm/3me
Cytomegalovirus
(CMV) Infection - Epidemiology Insights-2023-Japan - Visit at - http://mrr.cm/3mn
No comments:
Post a Comment
Note: only a member of this blog may post a comment.